Clinical Trials Directory

Trials / Terminated

TerminatedNCT03198221

Comparison of Clenpiq vs Golytely Bowel Preparation

Randomized Comparison of the Impact of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Versus Polyethylene Glycol Bowel Preparation on Inpatient Colonoscopy Quality Parameters

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
14 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective randomized study which will be done at main campus Cleveland Clinic. The investigators will be comparing the colon cleansing by the Boston Bowel Preparation Scale in participants undergoing colonoscopy as an inpatient at our hospital. Participants will be randomized to the the standard of care (4 Liter polyethylene glycol based preparation) or a low volume bowel preparation (sodium picosulfate, a stimulant laxative, magnesium oxide and anhydrous citric acid (SP/MC)). Both agents will either be administered as full dose the evening before or as split-dose on the evening before and on the day of the procedure.

Detailed description

The purpose of our study is to determine if a 4L bowel cleansing agent is more effective than a low volume bowel preparation, and if the time of dosing (single dose night before vs split dose) of the bowel preparation results in better bowel cleansing in participants undergoing colonoscopy. Eligible participants undergoing colonoscopy with conscious sedation will be randomly assigned to one of two bowel preparations and one of two dosing schemas of bowel preparation. Participants not eligible for conscious sedation and are undergoing colonoscopy with general anesthesia will be randomized only to the single dose arms of the study. Participants will complete a questionnaire while drinking the bowel preparation to determine timing and tolerability of the bowel preparation.

Conditions

Interventions

TypeNameDescription
DRUGGolytelybowel preparation
DRUGClenpiqbowel preparation

Timeline

Start date
2018-07-11
Primary completion
2019-03-26
Completion
2019-03-26
First posted
2017-06-26
Last updated
2021-03-04
Results posted
2021-03-04

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03198221. Inclusion in this directory is not an endorsement.